HEADER OXIDOREDUCTASE 26-FEB-15 5AJR TITLE STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX TITLE 2 WITH THE 1-TETRAZOLE DERIVATIVE VT-1161 ((R)-2-(2,4-DIFLUOROPHENYL)- TITLE 3 1, 1-DIFLUORO-3-(1H-TETRAZOL-1-YL)-1-(5-(4-(2,2,2-TRIFLUOROETHOXY) TITLE 4 PHENYL) PYRIDIN-2-YL)PROPAN-2-OL) COMPND MOL_ID: 1; COMPND 2 MOLECULE: STEROL 14-ALPHA DEMETHYLASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: 29-481; COMPND 5 SYNONYM: TC14DM, CYTOCHROME P450 51; COMPND 6 EC: 1.14.13.70; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA CRUZI; SOURCE 3 ORGANISM_TAXID: 5693; SOURCE 4 STRAIN: THLAHUEN; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HMS174; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PCW KEYWDS CYTOCHROME P450, CYP51, OXIDOREDUCTASE, MONOOXYGENASE, STEROL KEYWDS 2 BIOSYNTHESIS, EUKARYOTIC MEMBRANES, CYTOCHROME P450 FOLD, KEYWDS 3 ENDOPLASMIC RETICULUM MEMBRANE EXPDTA X-RAY DIFFRACTION AUTHOR Z.WAWRZAK,W.HOEKSTRA,G.I LEPESHEVA REVDAT 4 10-JAN-24 5AJR 1 REMARK REVDAT 3 10-FEB-16 5AJR 1 JRNL REVDAT 2 23-DEC-15 5AJR 1 AUTHOR JRNL REVDAT 1 02-DEC-15 5AJR 0 JRNL AUTH W.J.HOEKSTRA,T.Y.HARGROVE,Z.WAWRZAK,D.DA GAMA JAEN BATISTA, JRNL AUTH 2 C.F.DA SILVA,A.S.G.NEFERTITI,G.RACHAKONDA,R.J.SCHOTZINGER, JRNL AUTH 3 F.VILLALTA,M.D.N.C.SOEIRO,G.I.LEPESHEVA JRNL TITL CLINICAL CANDIDATE VT-1161'S ANTIPARASITIC EFFECT IN VITRO, JRNL TITL 2 ACTIVITY IN A MURINE MODEL OF CHAGAS DISEASE, AND STRUCTURAL JRNL TITL 3 CHARACTERIZATION IN COMPLEX WITH THE TARGET ENZYME CYP51 JRNL TITL 4 FROM TRYPANOSOMA CRUZI. JRNL REF ANTIMICROB.AGENTS CHEMOTHER. V. 60 1058 2015 JRNL REFN ISSN 0066-4804 JRNL PMID 26643331 JRNL DOI 10.1128/AAC.02287-15 REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0103 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 13254 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.266 REMARK 3 R VALUE (WORKING SET) : 0.266 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.400 REMARK 3 FREE R VALUE TEST SET COUNT : 759 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.82 REMARK 3 REFLECTION IN BIN (WORKING SET) : 943 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3870 REMARK 3 BIN FREE R VALUE SET COUNT : 54 REMARK 3 BIN FREE R VALUE : 0.4620 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3592 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 117.9 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.04000 REMARK 3 B22 (A**2) : 0.04000 REMARK 3 B33 (A**2) : -0.14000 REMARK 3 B12 (A**2) : 0.02000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.404 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.418 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 22.421 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3765 ; 0.002 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3630 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5106 ; 0.891 ; 1.997 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8354 ; 0.562 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 447 ; 7.377 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 168 ;37.490 ;23.452 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 665 ;19.161 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 29 ;19.934 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 548 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4182 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 869 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1794 ; 9.962 ;11.499 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1793 ; 9.965 ;11.497 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2239 ;14.894 ;17.235 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2240 ;14.890 ;17.238 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1970 ; 9.142 ;11.933 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1971 ; 9.140 ;11.931 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2867 ;14.109 ;17.622 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4820 ;20.138 ;93.743 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4821 ;20.136 ;93.740 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 5AJR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1290063161. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-DEC-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9787 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : BE LENSES DIAMOND LAUE REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14063 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 54.610 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 8.000 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.69000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER MR REMARK 200 STARTING MODEL: PDB ENTRY 3ZG2 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.91667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 147.83333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 147.83333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 73.91667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 28 REMARK 465 PRO A 222 REMARK 465 LEU A 479 REMARK 465 PRO A 480 REMARK 465 SER A 481 REMARK 465 HIS A 482 REMARK 465 HIS A 483 REMARK 465 HIS A 484 REMARK 465 HIS A 485 REMARK 465 HIS A 486 REMARK 465 HIS A 487 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 51 87.51 -150.18 REMARK 500 ALA A 115 -126.50 52.03 REMARK 500 SER A 206 -18.45 -46.79 REMARK 500 VAL A 245 -37.77 -39.96 REMARK 500 ASP A 272 6.46 -69.58 REMARK 500 LYS A 376 119.66 -39.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A1479 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 422 SG REMARK 620 2 HEM A1479 NA 98.8 REMARK 620 3 HEM A1479 NB 82.7 89.1 REMARK 620 4 HEM A1479 NC 81.6 175.0 86.0 REMARK 620 5 HEM A1479 ND 98.3 93.0 177.5 91.9 REMARK 620 6 VT1 A1480 NAF 172.4 84.1 90.3 94.9 88.5 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 1479 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VT1 A 1480 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE IS DESCRIBED IN LEPESHEVA ET AL. (2006) J. REMARK 999 BIOL.CHEM., 281, P.3577 DBREF 5AJR A 32 481 UNP Q7Z1V1 CP51_TRYCC 32 481 SEQADV 5AJR ALA A 28 UNP Q7Z1V1 EXPRESSION TAG SEQADV 5AJR LYS A 29 UNP Q7Z1V1 EXPRESSION TAG SEQADV 5AJR LYS A 30 UNP Q7Z1V1 EXPRESSION TAG SEQADV 5AJR THR A 31 UNP Q7Z1V1 EXPRESSION TAG SEQADV 5AJR HIS A 482 UNP Q7Z1V1 EXPRESSION TAG SEQADV 5AJR HIS A 483 UNP Q7Z1V1 EXPRESSION TAG SEQADV 5AJR HIS A 484 UNP Q7Z1V1 EXPRESSION TAG SEQADV 5AJR HIS A 485 UNP Q7Z1V1 EXPRESSION TAG SEQADV 5AJR HIS A 486 UNP Q7Z1V1 EXPRESSION TAG SEQADV 5AJR HIS A 487 UNP Q7Z1V1 EXPRESSION TAG SEQRES 1 A 460 ALA LYS LYS THR PRO PRO VAL TYR PRO VAL THR VAL PRO SEQRES 2 A 460 PHE LEU GLY HIS ILE VAL GLN PHE GLY LYS ASN PRO LEU SEQRES 3 A 460 GLU PHE MET GLN ARG CYS LYS ARG ASP LEU LYS SER GLY SEQRES 4 A 460 VAL PHE THR ILE SER ILE GLY GLY GLN ARG VAL THR ILE SEQRES 5 A 460 VAL GLY ASP PRO HIS GLU HIS SER ARG PHE PHE SER PRO SEQRES 6 A 460 ARG ASN GLU ILE LEU SER PRO ARG GLU VAL TYR THR ILE SEQRES 7 A 460 MET THR PRO VAL PHE GLY GLU GLY VAL ALA TYR ALA ALA SEQRES 8 A 460 PRO TYR PRO ARG MET ARG GLU GLN LEU ASN PHE LEU ALA SEQRES 9 A 460 GLU GLU LEU THR ILE ALA LYS PHE GLN ASN PHE VAL PRO SEQRES 10 A 460 ALA ILE GLN HIS GLU VAL ARG LYS PHE MET ALA GLU ASN SEQRES 11 A 460 TRP LYS GLU ASP GLU GLY VAL ILE ASN LEU LEU GLU ASP SEQRES 12 A 460 CYS GLY ALA MET ILE ILE ASN THR ALA CYS GLN CYS LEU SEQRES 13 A 460 PHE GLY GLU ASP LEU ARG LYS ARG LEU ASN ALA ARG HIS SEQRES 14 A 460 PHE ALA GLN LEU LEU SER LYS MET GLU SER SER LEU ILE SEQRES 15 A 460 PRO ALA ALA VAL PHE MET PRO TRP LEU LEU ARG LEU PRO SEQRES 16 A 460 LEU PRO GLN SER ALA ARG CYS ARG GLU ALA ARG ALA GLU SEQRES 17 A 460 LEU GLN LYS ILE LEU GLY GLU ILE ILE VAL ALA ARG GLU SEQRES 18 A 460 LYS GLU GLU ALA SER LYS ASP ASN ASN THR SER ASP LEU SEQRES 19 A 460 LEU GLY GLY LEU LEU LYS ALA VAL TYR ARG ASP GLY THR SEQRES 20 A 460 ARG MET SER LEU HIS GLU VAL CYS GLY MET ILE VAL ALA SEQRES 21 A 460 ALA MET PHE ALA GLY GLN HIS THR SER THR ILE THR THR SEQRES 22 A 460 SER TRP SER MET LEU HIS LEU MET HIS PRO LYS ASN LYS SEQRES 23 A 460 LYS TRP LEU ASP LYS LEU HIS LYS GLU ILE ASP GLU PHE SEQRES 24 A 460 PRO ALA GLN LEU ASN TYR ASP ASN VAL MET ASP GLU MET SEQRES 25 A 460 PRO PHE ALA GLU ARG CYS VAL ARG GLU SER ILE ARG ARG SEQRES 26 A 460 ASP PRO PRO LEU LEU MET VAL MET ARG MET VAL LYS ALA SEQRES 27 A 460 GLU VAL LYS VAL GLY SER TYR VAL VAL PRO LYS GLY ASP SEQRES 28 A 460 ILE ILE ALA CYS SER PRO LEU LEU SER HIS HIS ASP GLU SEQRES 29 A 460 GLU ALA PHE PRO ASN PRO ARG LEU TRP ASP PRO GLU ARG SEQRES 30 A 460 ASP GLU LYS VAL ASP GLY ALA PHE ILE GLY PHE GLY ALA SEQRES 31 A 460 GLY VAL HIS LYS CYS ILE GLY GLN LYS PHE ALA LEU LEU SEQRES 32 A 460 GLN VAL LYS THR ILE LEU ALA THR ALA PHE ARG GLU TYR SEQRES 33 A 460 ASP PHE GLN LEU LEU ARG ASP GLU VAL PRO ASP PRO ASP SEQRES 34 A 460 TYR HIS THR MET VAL VAL GLY PRO THR LEU ASN GLN CYS SEQRES 35 A 460 LEU VAL LYS TYR THR ARG LYS LYS LYS LEU PRO SER HIS SEQRES 36 A 460 HIS HIS HIS HIS HIS HET HEM A1479 43 HET VT1 A1480 37 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM VT1 (R)-2-(2,4-DIFLUOROPHENYL)-1,1-DIFLUORO-3-(1H-TETRAZOL- HETNAM 2 VT1 1-YL)-1-(5-(4-(2,2,2-TRIFLUOROETHOXY)PHENYL)PYRIDIN-2- HETNAM 3 VT1 YL)PROPAN-2-OL HETSYN HEM HEME FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 VT1 C23 H16 F7 N5 O2 HELIX 1 1 HIS A 44 ASN A 51 1 8 HELIX 2 2 ASN A 51 LYS A 64 1 14 HELIX 3 3 ASP A 82 HIS A 84 5 3 HELIX 4 4 GLU A 85 SER A 91 1 7 HELIX 5 5 PRO A 99 THR A 104 1 6 HELIX 6 6 MET A 106 GLY A 111 1 6 HELIX 7 7 VAL A 114 ALA A 118 5 5 HELIX 8 8 PRO A 119 GLU A 133 1 15 HELIX 9 9 ALA A 137 GLN A 140 5 4 HELIX 10 10 ASN A 141 TRP A 158 1 18 HELIX 11 11 LEU A 167 PHE A 184 1 18 HELIX 12 12 GLY A 185 LEU A 192 1 8 HELIX 13 13 ASN A 193 SER A 206 1 14 HELIX 14 14 ILE A 209 PHE A 214 5 6 HELIX 15 15 MET A 215 ARG A 220 5 6 HELIX 16 16 GLN A 225 LYS A 249 1 25 HELIX 17 17 ASP A 260 ALA A 268 1 9 HELIX 18 18 SER A 277 HIS A 309 1 33 HELIX 19 19 ASN A 312 ASP A 324 1 13 HELIX 20 20 ASN A 331 MET A 336 1 6 HELIX 21 21 MET A 339 ASP A 353 1 15 HELIX 22 22 SER A 383 HIS A 388 1 6 HELIX 23 23 ALA A 417 LYS A 421 5 5 HELIX 24 24 GLY A 424 GLU A 442 1 19 HELIX 25 25 LEU A 466 GLN A 468 5 3 SHEET 1 AA 5 VAL A 67 ILE A 72 0 SHEET 2 AA 5 GLN A 75 VAL A 80 -1 O GLN A 75 N ILE A 72 SHEET 3 AA 5 ILE A 379 CYS A 382 1 O ILE A 379 N THR A 78 SHEET 4 AA 5 VAL A 359 VAL A 363 -1 O VAL A 359 N CYS A 382 SHEET 5 AA 5 LEU A 97 SER A 98 -1 O SER A 98 N MET A 362 SHEET 1 AB 3 VAL A 164 ASN A 166 0 SHEET 2 AB 3 LEU A 470 ARG A 475 -1 O VAL A 471 N ILE A 165 SHEET 3 AB 3 TYR A 443 LEU A 447 -1 O ASP A 444 N THR A 474 SHEET 1 AC 2 VAL A 367 VAL A 369 0 SHEET 2 AC 2 TYR A 372 VAL A 374 -1 O TYR A 372 N VAL A 369 SHEET 1 AD 2 PRO A 455 ASP A 456 0 SHEET 2 AD 2 GLY A 463 PRO A 464 -1 O GLY A 463 N ASP A 456 LINK SG CYS A 422 FE HEM A1479 1555 1555 2.26 LINK FE HEM A1479 NAF VT1 A1480 1555 1555 2.21 SITE 1 AC1 17 TYR A 103 ALA A 288 GLY A 292 THR A 295 SITE 2 AC1 17 THR A 299 VAL A 359 ARG A 361 GLY A 414 SITE 3 AC1 17 PHE A 415 GLY A 416 VAL A 419 HIS A 420 SITE 4 AC1 17 LYS A 421 CYS A 422 ILE A 423 GLY A 424 SITE 5 AC1 17 VT1 A1480 SITE 1 AC2 11 TYR A 103 MET A 106 TYR A 116 ALA A 287 SITE 2 AC2 11 ALA A 291 THR A 295 LEU A 356 MET A 358 SITE 3 AC2 11 MET A 360 MET A 460 HEM A1479 CRYST1 63.060 63.060 221.750 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015858 0.009156 0.000000 0.00000 SCALE2 0.000000 0.018311 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004510 0.00000